42,766 Shares in Cencora, Inc. $COR Purchased by Corient Private Wealth LP

Corient Private Wealth LP purchased a new position in shares of Cencora, Inc. (NYSE:COR) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 42,766 shares of the company’s stock, valued at approximately $12,101,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. BlackRock Inc. acquired a new position in shares of Cencora during the 2nd quarter worth approximately $5,154,136,000. T. Rowe Price Investment Management Inc. lifted its holdings in Cencora by 160.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,700,091 shares of the company’s stock valued at $2,262,956,000 after purchasing an additional 4,123,795 shares during the last quarter. Bank of America Corp DE bought a new position in Cencora during the second quarter worth $1,056,625,000. Norges Bank bought a new position in Cencora during the fourth quarter worth $822,506,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of Cencora in the second quarter valued at $483,772,000. Institutional investors own 97.52% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on COR. Morgan Stanley increased their price objective on shares of Cencora from $342.00 to $346.00 and gave the company an “overweight” rating in a research report on Friday, August 7th. Robert W. Baird set a $370.00 price target on shares of Cencora in a research note on Thursday, August 6th. UBS Group increased their price target on shares of Cencora from $412.00 to $430.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Barclays cut their price objective on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, June 10th. Finally, JPMorgan Chase & Co. upped their target price on Cencora from $382.00 to $390.00 and gave the company an “overweight” rating in a research report on Friday, August 7th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $370.85.

Cencora Trading Up 0.3%

Shares of Cencora stock opened at $322.12 on Friday. The company has a debt-to-equity ratio of 3.53, a quick ratio of 0.58 and a current ratio of 0.93. The firm has a 50-day moving average of $307.38 and a 200-day moving average of $310.88. Cencora, Inc. has a 52-week low of $244.82 and a 52-week high of $377.54. The stock has a market cap of $61.47 billion, a PE ratio of 23.93, a PEG ratio of 1.85 and a beta of 0.57.

Cencora (NYSE:COR) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $4.48 earnings per share for the quarter, topping the consensus estimate of $4.35 by $0.13. The business had revenue of $84.75 billion during the quarter, compared to analysts’ expectations of $84.31 billion. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The business’s revenue was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $4.00 EPS. As a group, sell-side analysts forecast that Cencora, Inc. will post 17.87 EPS for the current year.

Cencora Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be paid a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Friday, August 14th. Cencora’s payout ratio is 17.83%.

Cencora announced that its Board of Directors has initiated a share repurchase program on Thursday, May 21st that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the company to purchase up to 3.9% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s leadership believes its stock is undervalued.

Insider Activity at Cencora

In other Cencora news, EVP Elizabeth S. Campbell sold 11,300 shares of Cencora stock in a transaction on Monday, August 24th. The stock was sold at an average price of $324.12, for a total value of $3,662,556.00. Following the completion of the transaction, the executive vice president directly owned 19,455 shares of the company’s stock, valued at $6,305,754.60. The trade was a 36.74% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Lauren M. Tyler bought 550 shares of the business’s stock in a transaction dated Monday, June 22nd. The shares were bought at an average price of $270.23 per share, with a total value of $148,626.50. Following the completion of the transaction, the director owned 4,359 shares in the company, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 0.38% of the company’s stock.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.